Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation

Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial

10 p | 4 | 3

Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy

10 p | 17 | 3

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

9 p | 13 | 2

Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma – clinical application of health-related quality-of-life data

11 p | 17 | 2

Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma

9 p | 9 | 2

Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma

11 p | 17 | 2

Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma

9 p | 11 | 1

Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

9 p | 10 | 1

Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery

12 p | 3 | 1